The science behind Revalor®-XH
Proprietary delayed and extended release technology delivers trenbolone acetate and estradiol in a unique
Designed for heifers fed in confinement, Revalor®-XH delivers the combination
of trenbolone acetate and estradiol of two-implant programs in a single administration, thanks to its
unique, delayed and extended release technology.
Each Revalor®-XH implant consists of 10 small pellets
- The first four pellets are uncoated, which allows them to go to work immediately after
- The other six pellets are coated with a patented polymer. The delayed-release pellets
take effect 70 days after implanting, providing the performance of a moderate potency terminal implant
without the need for reprocessing.
End section - Uncoated (25x)
End section - Coated (25x)
Microscopic view of coated and uncoated pellets
- Revalor®-XH contains trenbolone acetate and estradiol in a 10:1 ratio.
- Each pellet contains 20 mg of trenbolone acetate and 2 mg of estradiol, for a total dose of 200 mg of
trenbolone acetate and 20 mg of estradiol.
REVALOR® is a registered trademark of Intervet International B.V. Used under